Introducing the new AltIndexLearn more
Kairos Pharma

Kairos Pharma (KAPA) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Kairos Pharma is 54 — signals are mixed heading into the print. Underlying trend: 1 of 4 tracked signals trending up over the last 3 months.

Next report
Monday, August 10, 2026
EPS Estimate
AltIndex AI Score
54
AI Prediction
Mixed signals

KAPA stock price — last 3 months

Kairos Pharma (KAPA) is trading at $0.35, down 23.9% over the last 3 months (from $0.46 three months ago).

What the alt-data signals say about Kairos Pharma right now

Trends across the last 3 months — the run-up to Kairos Pharma’s next earnings print.

Signal Current 3-month change
LinkedIn headcount 1 → +0.0%
Web traffic 2,264 ↑ +44.3%
Instagram followers 75 → -1.3%
X followers 255 → +2.8%

Full daily-resolution trend charts on every signal are on the KAPA ticker page.

Get alerted when KAPA signals inflect

AltIndex stock alerts fire when alt-data on KAPA breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Kairos Pharma earnings: frequently asked questions

When does Kairos Pharma report earnings next?
Kairos Pharma (KAPA) is scheduled to report next earnings on Monday, August 10, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Kairos Pharma going into earnings?
Current AI Score on Kairos Pharma: 54 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the KAPA ticker page.
What is the EPS estimate for Kairos Pharma?
EPS estimate for Kairos Pharma’s next quarter isn’t available yet. We refresh estimates daily as analysts publish their numbers.
How accurate are AltIndex’s earnings predictions for Kairos Pharma?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Kairos Pharma?
Visit https://altindex.com/ticker/kapa for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Kairos Pharma reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add KAPA to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on KAPA

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Kairos Pharma — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in